Home > News > Labopharm reports results for second quarter fiscal 2004
July 28th, 2004
Labopharm reports results for second quarter fiscal 2004
Labopharm Inc. (TSX: DDS) today reported its results for the second quarter of fiscal 2004 ended June 30, 2004. Net loss for the second quarter of fiscal 2004 was $7.1 million, or $0.18 per share, compared with $8.8 million, or $0.28 per share, for the second quarter of fiscal 2003.
Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014
Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 4, 2014 January 15th, 2014
Nanobiotix 2013 Review: Significant Corporate and Clinical Progress January 7th, 2014